ntravenosa para el control del vértigo en la enfermedad de Meniere

Objective: To verify the result in the use of intratympanic corticosteroids, combined with intravenous, in patients with Meniere disease (MD). Material and methods: Ten patients with vertigo due to MD in stages 4-5 or 6 were included in the study. Combined intratympanic and intra- venous dexomethasone was infiltrated. The number of epi- sodes among the months 18 and 24 of treatment, com- paring them with the number of episodes 6 months before treatment (according to the norms of the American commit- tee for the hearing and the equilibrium, 1995) are studied. Results: All patients improved significantly. In one of them treatment was repeated after 6 months. A number of pa- tients with hearing improvement were observed. Conclu- sions: The use of combined dexomethasone may be useful to control vertigo due to MD, to avoid or to be a prior step to other more aggressive treatments.